z-logo
open-access-imgOpen Access
Severe interstitial lung disease following treatment with certolizumab pegol: a case report
Author(s) -
Jakob Lager,
Ole Hilberg,
Anders Løkke,
Elisabeth Bendstrup
Publication year - 2013
Publication title -
european respiratory review
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.565
H-Index - 66
eISSN - 1600-0617
pISSN - 0905-9180
DOI - 10.1183/09059180.00002013
Subject(s) - medicine , certolizumab pegol , interstitial lung disease , lung , disease , adalimumab

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom